Eptifibatide Alternatives Compared
Eptifibatide | Clopidogrel | Plavix (clopidogrel) |
|
---|
Eptifibatide | Clopidogrel | Plavix (clopidogrel) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Acute Coronary Syndrome, Angina, Heart Attack, Percutaneous Coronary Intervention. Eptifibatide may also be used for purposes not listed in this medication guide. |
Prescription only
Clopidogrel may be given to reduce the risk of a heart attack or stroke in certain cardiovascular conditions or following a heart attack or ischemic stroke. People who are poor metabolizers of... View more |
Prescription only
Plavix may be given to reduce the risk of a heart attack or stroke in certain cardiovascular conditions or following a heart attack or ischemic stroke. People who are poor metabolizers at CYP2C19 may... View more |
Related suggestions Heart Attack (Myocardial Infarction)
Acute Coronary Syndrome
Percutaneous Coronary Intervention
|
|||||||||||||||||||||||
More about Eptifibatide | More about Clopidogrel | More about Plavix (clopidogrel) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Eptifibatide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Clopidogrel has an average rating of 7.2 out of 10 from a total of 105 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Plavix has an average rating of 7.5 out of 10 from a total of 73 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Eptifibatide side effects |
View all Clopidogrel side effects |
View all Plavix side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Eptifibatide prices |
View all Clopidogrel prices |
View all Plavix prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Integrilin | Plavix |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
2.5 hours |
8 hours |
8 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 151 drugs are known to interact with Eptifibatide:
|
A total of 281 drugs are known to interact with Clopidogrel:
|
A total of 281 drugs are known to interact with Plavix:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
November 17, 1997 |
November 17, 1997 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.